Remove products
article thumbnail

Novo Nordisk attracts lawmakers' scrutiny after dropping discounted insulin product Levemir

Fierce Pharma

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for (..)

327
327
article thumbnail

Daiichi Sankyo plots €1B expansion to beef up antibody-drug conjugate production in Germany

Fierce Pharma

After laying out plans to absorb a pair of production subsidiaries in October, Japan’s Daiichi Sankyo is doubling down on its quest to dominate the red-hot antibody-drug conjugate (ADC) field. billion) into an expansion of its production facility in Pfaffenhofen an der Ilm, Germany.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic

Fierce Pharma

Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victo | Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing (..)

article thumbnail

Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond

Fierce Pharma

Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.

345
345
article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements.

article thumbnail

Pfizer warns of further sales decline for COVID products, plots $500M in additional cost cuts

Fierce Pharma

billion, largely because of the plummeting demand for its COVID-19 products. The company expects revenue to reach between $58.5 billion and $61.5 billion next year, coming up short of the analyst consensus of $63.2

Sales 362
article thumbnail

Pfizer cost-savings campaign reaches Ireland, where 100 production workers will lose jobs

Fierce Pharma

billion by 2024 amid declining demand for its COVID-19 products. . | The layoffs at Pfizer's Newbridge, Kildare, manufacturing site are the latest in the company's effort to save $3.5

article thumbnail

Commercial Drug Sourcing for Clinical Trials

Sponsors can face a number of challenges when trying to obtain these critical supplies for their studies, including addressing product lead times, availability, expiry limitations, safety and cost, among others.

article thumbnail

Going to Market Smarter in the New Economy

To succeed, you must change the way you conceive and build new products as a digital business. In 2022, as companies continue to move more functions online, employees will take a more virtual -- and flexible -- mindset and lifestyle in parallel to the digitization of businesses. Download the report today to discover more!

article thumbnail

How Intent Data Helps Marketers Convert A-List Accounts

By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return.

article thumbnail

5 Essential Pieces of a Prospecting Solution

Using ZoomInfo’s exclusive research, third-party studies, and analyst briefs, this eBook aims to help B2B sales leaders better understand: Different ways prospecting solutions maximize sales productivity and effectiveness. Five essential features to consider when assessing the vendor landscape.

article thumbnail

Buyer’s Checklist: How to Evaluate a B2B Contact Data Provider

Leveraging a data provider to help identify and connect with qualified prospects supports company revenue goals by alleviating common headaches associated with prospecting research and empowers sales productivity. So what’s the problem? Many organizations fail to properly evaluate vendors during the selection process.

article thumbnail

How to Overcome the Pain Points of Your CRM

When used effectively, a CRM can be the lifeblood of your sales team – keeping everyone organized, efficient, and at peak productivity. The promise of a CRM ( customer relationship management ) led organizations to believe each could digitally transform its businesses through tracking touchpoints throughout the buyer’s journey. The result?

article thumbnail

Forrester Research Report: How Sales and Marketing Intelligence Drive Improved Business Outcomes

Check out this latest report to gain insight into best practices (and benefits) for B2B data management including how: Automating tasks and improving data quality would increase sales staff satisfaction and productivity. B2B organizations struggle with bad data.

article thumbnail

What We Learned From Our Own Data-Driven ABM Strategy

In just 90 days, we were able to increase our pipeline by 114% and the customer base for this particular product by 30%. talking points, we thought it would be more helpful to examine an ABM program that ZoomInfo executed.